Moneycontrol
HomeNewsBusinessPharmeasy to seek funding from Manipal only in case of shortfall in rights issue
Trending Topics

Pharmeasy to seek funding from Manipal only in case of shortfall in rights issue

The Manipal Group's family office had made a binding offer to invest up to Rs 1,300 crore in the online pharmacy

July 18, 2023 / 07:54 IST
Story continues below Advertisement

Pharmeasy to seek funding.

API Holdings, the parent of Pharmeasy, plans to approach the Manipal Group only to cover any shortfall that may occur if all shareholders do not participate in its rights issue, said people with direct knowledge of the matter. The online pharmacy plans to raise up to Rs 3,000 crore to repay debt.

The Manipal Group's family office had made a binding offer to invest up to Rs 1,300 crore in the online pharmacy, the people said. The API Holdings board is said to have approved the offer but only to cover the remaining amount if not all shareholders participate in the rights issue.

Story continues below Advertisement

It took this decision after a section of investors expressed reservations on the sale of shares to the Manipal Group at a low valuation in a July 17 meeting with the management.

The post-money valuation of API Holdings is expected to be around Rs 6,000-7,000 crore ($730-853 million), a massive markdown from its last fundraise, which valued it at $2.8 billion.